查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888745

遺傳疾病診斷市場規模、佔有率和趨勢分析報告：按技術、通路、應用、產品、最終用途、地區和細分市場預測（2025-2033 年）

Genetic Disease Diagnostics Market Size, Share & Trends Analysis Report By Technology (NGS, PCR-based Testing), By Channel (Online, Offline), By Application, By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

遺傳疾病診斷市場摘要

全球遺傳疾病診斷市場預計在 2024 年達到 117.1 億美元，預計到 2033 年將達到 578.3 億美元。

預計從 2025 年到 2033 年，該市場將以 19.1% 的複合年成長率成長。市場成長的主要驅動力是技術進步、對個人化醫療日益成長的需求以及對新生兒篩檢需求的增加。

由於攜帶者篩檢、非侵入性產前檢測 (NIPT) 和體外受精 (IVF) 相關基因分析技術的進步，產科基因檢測正在經歷重大變化。這些創新正在推動市場持續成長，尤其是在已開發經濟體和新興經濟體。

藥物基因組學檢測在幫助臨床醫生為患者選擇最有效的藥物和合適的劑量方面正變得日益重要。分子病理學協會 (AMP) 正引領實驗室間此類檢測的標準化工作。 2022 年 8 月，AMP 發布了針對 NUDT15 和 TPMT 等基因的臨床基因分型檢測的設計和檢驗建議。這些指南將為實驗室提供一組最低限度的等位基因，以識別可能存在硫嘌呤毒性風險增加的患者，有助於提高治療的安全性和有效性。

新型檢測方法的引入有望顯著降低治療成本，避免過度處方和過量用藥，從而降低藥品價格，同時減少因藥物不良反應引起的併發症和住院風險，預計將對市場成長產生積極影響。例如，2025年10月，總部位於印度海得拉巴的AIG醫院與GenepowerRx公司合作推出了一項藥物基因組學檢測，該檢測可以幫助醫生根據患者的基因組成來開立處方並製定治療方案。

由於次世代定序(NGS) 技術的進步，全基因測序(WGS) 的成本已降至 100 美元以下。許多公司正在推出基於次世代定序(NGS)、全基因測序和先進晶片技術的新型檢測方法，這些方法能夠提供更高的準確性、覆蓋範圍和更快的檢測速度。例如，CENTOGENE 公司推出了“CentoGenome Ultra-Fast”，這是一款全基因測序工具，可在五個工作天內完成遺傳疾病的診斷。快速診斷和早期療育有助於採取適當的治療措施，從而改善患者預後，並減少急診和加護病房的併發症。

儘管取得了這些進展，但高昂的檢測成本可能成為開發中國家市場成長的障礙。價格從不到100美元到超過2000美元不等，取決於檢測的複雜程度，需要採集多個家庭成員樣本的檢測費用更高。檢測結果可能需要幾週才能出來。在某些情況下，如果由醫療專業人員開立處方，醫療保險會涵蓋這些檢測，但不同保險公司和保單的承保範圍差異很大。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 遺傳疾病診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 遺傳疾病診斷市場分析工具
    • 波特分析
    • PESTEL 分析

第4章：遺傳疾病診斷市場：依技術分類的估算與趨勢分析

  • 按技術分類的市場佔有率（2024 年和 2033 年）
  • 全球遺傳疾病診斷市場：技術展望
  • 市場規模、預測與趨勢分析（2021-2033）
    • 次世代定序
    • 陣列技術
    • 基於PCR的檢測
    • FISH
    • 其他

第5章：遺傳疾病診斷市場：按應用分類的估算與趨勢分析

  • 按應用領域分類的市場佔有率（2024 年和 2033 年）
  • 全球遺傳疾病診斷市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析（2021-2033）
    • 祖籍/民族
    • 房產篩檢
    • 遺傳疾病帶因者狀態
    • 新生兒篩檢
    • 健康與保健－傾向、風險與趨勢

第6章：遺傳疾病診斷市場：依產品分類的估算與趨勢分析

  • 按產品分類的市場佔有率（2024 年和 2033 年）
  • 全球遺傳疾病診斷市場：產品展望
  • 市場規模、預測與趨勢分析（2021-2033）
    • 消耗品
    • 裝置
    • 軟體和服務

第7章：遺傳疾病診斷市場：按通路分類的估算和趨勢分析

  • 按通路分類的市場佔有率（2024 年和 2033 年）
  • 全球遺傳疾病診斷市場：通路
  • 市場規模、預測與趨勢分析（2021-2033）
    • 線上
    • 離線

第8章：遺傳疾病診斷市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率（2024 年和 2033 年）
  • 全球遺傳疾病診斷市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析（2021-2033）
    • 醫院和診所
    • 診斷檢查室
    • 其他

第9章：遺傳疾病診斷市場：區域估算與趨勢分析

  • 按地區分類的市場佔有率（2024 年和 2033 年）
  • 全球遺傳疾病診斷市場：區域展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • 24 genetics
    • Circle DNA
    • TellmeGen
    • 23andme
    • AncestryDNA
    • MyDNA
    • Igenomix
    • Myriad Genetics, Inc
    • Illumina, Inc.
    • MyHeritage Ltd.
    • Everly Well.
    • VitaGen
    • Mapmygenome
    • Helix OpCo LLC
    • Color Genomics, Inc.
    • Amgen, Inc.
    • Beyond Nutrition Health and Wellness Services DMCC.
Product Code: GVR-4-68040-814-0

Genetic Disease Diagnostics Market Summary

The global genetic disease diagnostics market size was estimated at USD 11.71 billion in 2024 and is projected to reach USD 57.83 billion by 2033, growing at a CAGR of 19.1% from 2025 to 2033. The market is primarily driven by technological advancements, increasing demand for personalized medicine, and growing demand for newborn screening..

Genetic testing in maternity care is undergoing a major transformation, driven by advancements in carrier screening, non-invasive prenatal testing (NIPT), and IVF-related genetic analyses. These innovations are fueling consistent market growth, especially across both established and emerging economies.

Pharmacogenomics testing is increasingly vital in helping clinicians choose the most effective medications and appropriate dosages for patients. The Association for Molecular Pathology (AMP) has made strides toward standardizing these tests across laboratories. In August 2022, the AMP released recommendations for designing and validating clinical genotyping assays for genes like NUDT15 and TPMT. These guidelines provide a minimum set of alleles for laboratories to identify patients who may be at a higher risk of thiopurine toxicity, thereby improving treatment safety and efficacy.

The introduction of new tests that can considerably reduce treatment costs and help lower pharmaceutical expenses by preventing overprescription and excessive dosing, while also reducing the risk of complications and hospitalizations resulting from adverse drug reactions, is expected to impact market growth positively. For instance, in October 2025, AIG Hospitals, a Hyderabad (India) based hospital, in collaboration with GenepowerRx, launched a pharmacogenomics test that would help doctors to prescribe medicines or decide on a treatment plan based on the patient's genetic makeup.

Driven primarily by advancements in Next-Generation Sequencing (NGS) technology, WGS costs are falling toward the sub-USD 100 threshold. Many companies have launched new tests based on next-generation sequencing (NGS), whole-genome sequencing, and advanced array technologies, offering higher accuracy, coverage, and rapid results. For instance, CENTOGENE launched CentoGenome Ultra-Fast, a whole-genome sequencing tool for diagnosing genetic diseases in five business days. Rapid diagnosis and early intervention facilitate timely treatment, which in turn improves patient outcomes and reduces complications in emergency cases and the ICU.

Despite these advancements, the high cost of the test may impede market growth in developing countries. Depending on the test's complexity, costs can range from under $100 to over $2,000, with higher costs associated with tests that require multiple family samples. Results may also take weeks to arrive. In some instances, health insurance covers these tests when prescribed by a medical professional, but coverage varies widely across insurers and policies.

Global Genetic Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global genetic disease diagnostics market report based on technology, application, product, channel, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Next Generation Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Ancestry & Ethnicity
  • Traits Screening
  • Genetic Disease Carrier Status
  • New Baby Screening
  • Health and Wellness-Predisposition/Risk/Tendency
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Equipment
  • Software & Services
  • Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Offline
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Product
    • 1.2.4. Channel
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Product outlook
    • 2.2.4. Channel outlook
    • 2.2.5. End Use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Genetic Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological Advancements in Diagnostic Testing
      • 3.2.1.2. Growing Burden of Chronic and Infection Diseases
      • 3.2.1.3. Rising Awareness and Demand for Personalized Medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Required Skilled Labors
  • 3.3. Genetic Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Genetic Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Genetic Disease Diagnostics Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 4.4.1. Next-Generation Sequencing
      • 4.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Array Technology
      • 4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. PCR - Based Testing
      • 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. FISH
      • 4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Genetic Disease Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Genetic Disease Diagnostics Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 5.4.1. Ancestry & Ethnicity
      • 5.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 5.4.2. Traits Screening
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Genetic Disease Carrier Status
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. New Baby Screening
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Health and Wellness - Predisposition/ Risk/tendency
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Genetic Disease Diagnostics Market: Product Estimates & Trend Analysis

  • 6.1. Product Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Genetic Disease Diagnostics Market by Product Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 6.4.1. Consumables
      • 6.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 6.4.2. Equipment
      • 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Software & Services
      • 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Genetic Disease Diagnostics Market: Channel Estimates & Trend Analysis

  • 7.1. Channel Market Share, 2024 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Global Genetic Disease Diagnostics Market by Channel Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 7.4.1. Online
      • 7.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.2. Offline
      • 7.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Genetic Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2024 & 2033
  • 8.2. Segment Dashboard
  • 8.3. Global Genetic Disease Diagnostics Market by End Use Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 8.4.1. Hospitals & Clinics
      • 8.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 8.4.2. Diagnostic Laboratories
      • 8.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Others
      • 8.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Genetic Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2024
    • 10.3.4. 24 genetics
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Circle DNA
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. TellmeGen
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. 23andme
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. AncestryDNA
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. MyDNA
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Igenomix
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Myriad Genetics, Inc
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Illumina, Inc.
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. MyHeritage Ltd.
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Everly Well.
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. VitaGen
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Mapmygenome
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Helix OpCo LLC
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Color Genomics, Inc.
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Amgen, Inc.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Product benchmarking
      • 10.3.19.4. Strategic initiatives
    • 10.3.20. Beyond Nutrition Health and Wellness Services DMCC.
      • 10.3.20.1. Company overview
      • 10.3.20.2. Financial performance
      • 10.3.20.3. Product benchmarking
      • 10.3.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 4 Global Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 6 Global Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 7 Global Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 8 Global Genetic Disease Diagnostics Market, by Region, 2021 - 2033 (USD Million)
  • Table 9 North America Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 10 North America Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 11 North America Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 12 North America Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 13 North America Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 14 North America Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 17 U.S. Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 U.S. Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 19 U.S. Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Canada Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 21 Canada Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Canada Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Canada Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 24 Canada Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 27 Europe Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 29 Europe Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 30 Europe Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 31 Germany Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 32 Germany Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 33 Germany Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 34 Germany Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 35 Germany Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36 UK Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37 UK Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 38 UK Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 UK Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 40 UK Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 France Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 42 France Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 France Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 44 France Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 45 France Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Italy Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 47 Italy Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Italy Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Italy Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 50 Italy Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Spain Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 52 Spain Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Spain Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 54 Spain Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 55 Spain Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 56 Denmark Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57 Denmark Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 58 Denmark Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 60 Denmark Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Sweden Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 62 Sweden Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 63 Sweden Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Sweden Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 65 Sweden Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Norway Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 67 Norway Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Norway Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 69 Norway Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 70 Norway Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 Asia Pacific Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 72 Asia Pacific Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 73 Asia Pacific Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 74 Asia Pacific Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77 China Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 China Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 79 China Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 China Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 81 China Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Japan Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 83 Japan Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 84 Japan Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 85 Japan Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 86 Japan Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 India Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 88 India Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 India Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 90 India Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 91 India Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 South Korea Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 93 South Korea Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 South Korea Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 95 South Korea Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 96 South Korea Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 97 Australia Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 98 Australia Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 99 Australia Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 100 Australia Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 101 Australia Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 102 Thailand Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Thailand Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 104 Thailand Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 105 Thailand Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 106 Thailand Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 107 Latin America Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 108 Latin America Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 109 Latin America Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 110 Latin America Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 111 Latin America Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 112 Latin America Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Brazil Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 114 Brazil Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Brazil Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 116 Brazil Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 117 Brazil Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 118 Mexico Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 119 Mexico Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 120 Mexico Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 121 Mexico Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 122 Mexico Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 123 Argentina Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Argentina Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 125 Argentina Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 126 Argentina Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 127 Argentina Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 134 South Africa Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 135 South Africa Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 136 South Africa Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 137 South Africa Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 138 South Africa Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 144 UAE Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 145 UAE Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 146 UAE Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 147 UAE Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 148 UAE Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Genetic Disease Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Genetic Disease Diagnostics Market, Technology Movement Analysis
  • Fig. 16 Global Genetic Disease Diagnostics Market, for Next Generation Sequencing, 2021 - 2033 (USD Million)
  • Fig. 17 Global Genetic Disease Diagnostics Market, for Array Technology, 2021 - 2033 (USD Million)
  • Fig. 18 Global Genetic Disease Diagnostics Market, for PCR-based Testing, 2021 - 2033 (USD Million)
  • Fig. 19 Global Genetic Disease Diagnostics Market, for FISH, 2021 - 2033 (USD Million)
  • Fig. 20 Global Genetic Disease Diagnostics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 21 Global Genetic Disease Diagnostics Market, Application Movement Analysis
  • Fig. 22 Global Genetic Disease Diagnostics Market, for Ancestry & Ethnicity, 2021 - 2033 (USD Million)
  • Fig. 23 Global Genetic Disease Diagnostics Market, for Traits Screening, 2021 - 2033 (USD Million)
  • Fig. 24 Global Genetic Disease Diagnostics Market, for Genetic Disease Carrier Status, 2021 - 2033 (USD Million)
  • Fig. 25 Global Genetic Disease Diagnostics Market, for New Baby Screening, 2021 - 2033 (USD Million)
  • Fig. 26 Global Genetic Disease Diagnostics Market, for Health and Wellness - Predisposition/Risk/ Tendency, 2021 - 2033 (USD Million)
  • Fig. 27 Global Genetic Disease Diagnostics Market, Product Movement Analysis
  • Fig. 28 Global Genetic Disease Diagnostics Market, for Consumables, Movement Analysis
  • Fig. 29 Global Genetic Disease Diagnostics Market, for Equipment, 2021 - 2033 (USD Million)
  • Fig. 30 Global Genetic Disease Diagnostics Market, for Software & Services, 2021 - 2033 (USD Million)
  • Fig. 31 Global Genetic Disease Diagnostics Market, Channel Movement Analysis
  • Fig. 32 Global Genetic Disease Diagnostics Market, for Online, 2021 - 2033 (USD Million)
  • Fig. 33 Global Genetic Disease Diagnostics Market, for Offline, 2021 - 2033 (USD Million)
  • Fig. 34 Global Genetic Disease Diagnostics Market, End Use Movement Analysis
  • Fig. 35 Global Genetic Disease Diagnostics Market, for Hospitals & Clinics, 2021 - 2033 (USD Million)
  • Fig. 36 Global Genetic Disease Diagnostics Market, for Diagnostic Laboratories, 2021 - 2033 (USD Million)
  • Fig. 37 Global Genetic Disease Diagnostics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 Regional Outlook, 2024 & 2033
  • Fig. 40 Global Genetic Disease Diagnostics Market, Region Movement Analysis
  • Fig. 41 North America Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 46 UK Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 47 France Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 55 China Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 56 India Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East and Africa Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)